Drawing for MINDWALK

USPTO serial 99046894

MINDWALK

Reviewed by CopyMark Law Group

Reg. 8425640Status 700Registered
Filing date
Status date
Registration date
Sep 1, 2026
Examiner
CHADAB, SETH WILLIG
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MINDWALK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott W. Johnston

Scott W. Johnston Merchant & Gould P.C.P.O. Box 2910Minneapolis, MN 55402-0910United States

Goods and services

ClassDescriptionStatusFirst use
001Antibodies for research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, diagnostic veterinary research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use, and scientific useACTIVENov 17, 2025
040Biomanufacturing for others, namely, generation and purification of antibodies for research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use, and scientific use; Biomanufacturing for others, namely, generation and purification of antibodies for therapeutic medical use, diagnostic veterinary use and therapeutic veterinary useACTIVENov 17, 2025
042Scientific and technological services as well as research and design relating thereto, namely, the development of a cloud-based solution to perform genetic research by applying algorithmic principles for the quick retrieval of biological sequence data on all molecular layers to enable analysis of big data; biological laboratory services; biological research and analysis, and development of biological samples, genetical, protein or sequence related data for medical use; biological laboratory services, namely, sequencing of biological samples, including DNA and RNA and analysis thereof; biological research, development and analysis of biological samples, including DNA and RNA; biological research, namely, identification and characterization of biopolymers, biological samples, biological sequences and biological particles; DNA sequencing services for therapeutic use, research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use and scientific use; Storage services for archiving electronic data, namely, electronic copies of DNA sequences; DNA sequencing services for scientific research purposes; Scientific and technological services as well as research and design relating thereto, namely, the development of a cloud-based solution to perform genetic research by applying algorithmic principles for the quick retrieval of biological sequence data on all molecular layers to enable analysis of big data and by applying algorithms for structural search and modelling; scientific and technological services, namely, scientific research, analysis and testing in the field of biology, biotechnology, genetics, pharmacy and medicine; biological research, development and analysis; biological analysis of biological samples, genetical, protein or sequence related data for medical use; Providing temporary used of non-downloadable cloud computing software for use in database management of biological samples, multi-omics, genetical, protein or sequence related data; Platform as a service (PAAS) featuring computer software platforms for database management of biological samples, multi-omics, genetical, protein or sequence related data; Software as a service (SAAS) services featuring software for database management of biological samples, multi-omics, genetical, protein or sequence related dataACTIVENov 17, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 1, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 13, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 13, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 7, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 21, 2026IUAFUSE AMENDMENT FILED—
Apr 21, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 11, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 21, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 26, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 26, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 20, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 25, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 25, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jul 25, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 25, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 25, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 24, 2025DOCKASSIGNED TO EXAMINER—
Jul 9, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 19, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 19, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance